NEULANDLAB
NIFTY500
Neuland Laboratories Ltd.
Pharma · NSE
₹17,666.00
1Y+46.6%
52-week range
₹10,569 – ₹19,747
From 52w high
-10.5%
RSI (14)
78.7
vs SMA 50 / 200
↑ 50 · ↑ 200
PE
125.8
Forward PE
51.9
ROE
—
Profit margin
2.3%
D/E
16.33
Dividend yield
0.07%
Quality score
19/100
Revenue growth
10.5%
Earnings growth
-60.1%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.